WINDLAS BIOTECH share price has zoomed 7% and is presently trading at Rs 829.7.
Meanwhile, the BSE HEALTHCARE index is at 40,806.1 (down 0.5%).
Among the top gainers in the BSE HEALTHCARE index today are APOLLO HOSPITALS (up 1.7%) and J.B.Chemicals (up 1.5%).
Divis Laboratories (down 4.1%) and IPCA Labs (down 3.7%) are among the top losers today.
Over the last one year, WINDLAS BIOTECH has moved up from Rs 384.0 to Rs 829.7, registering a gain of Rs 445.7 (up 116.1%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 40,806.1, registering a gain of 46.7% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 129.4%), GSK Pharma (up 99.8%) and Jubilant Pharmova (up 98.1%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,156.5 (up 0.3%).
The top gainers among the BSE Sensex today are TCS (up 2.0%) and HCl Tech. (up 1.8%). The most traded stocks in the BSE Sensex are Tata Steel and Infosys.
In the meantime, NSE Nifty is at 24,172.5 (up 0.1%). TCS and HCl Tech. are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 79,156.5, registering a gain of 13,754.6 points (up 21.0%).
WINDLAS BIOTECH net profit grew 48.5% YoY to Rs 170 million for the quarter ended March 2024, compared to a profit of Rs 114 million a year ago. Net sales rose 21.7% to Rs 1,713 million during the period as against Rs 1,407 million in January-March 2023.
For the year ended March 2023, WINDLAS BIOTECH reported 11.9% increase in net profit to Rs 426 million compared to net profit of Rs 381 million during FY22. Revenue of the company grew 10.1% to Rs 5,131 million during FY23.
The current Price to earnings ratio of WINDLAS BIOTECH, based on rolling 12 month earnings, stands at 29.8.
Equitymaster requests your view! Post a comment on "WINDLAS BIOTECH Gains 7%; BSE HEALTHCARE Index Down 0.5%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!